Pro-Substance P for Evaluation of Risk in Acute Myocardial Infarction
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Role for Substance P–Based Nociceptive Signaling in Progenitor Cell Activation and Angiogenesis During Ischemia in Mice and in Human SubjectsCirculation, 2012
- Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cellsCardiovascular Research, 2011
- Extensions of net reclassification improvement calculations to measure usefulness of new biomarkersStatistics in Medicine, 2010
- Interaction between Sensory C-fibers and Cardiac Mast Cells in Ischemia/Reperfusion: Activation of a Local Renin-Angiotensin System Culminating in Severe Arrhythmic DysfunctionThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Cardiac mast cells: the centrepiece in adverse myocardial remodellingCardiovascular Research, 2010
- Detection of stable N-terminal protachykinin A immunoreactivity in human plasma and cerebrospinal fluidPeptides, 2008
- Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formationBlood, 2008
- A Validated Prediction Model for All Forms of Acute Coronary SyndromeJAMA, 2004
- Actions of Tachykinins Within the Heart and Their Relevance to Cardiovascular DiseaseThe Japanese Journal of Pharmacology, 2000
- Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta.Journal of Clinical Investigation, 1987